Figure 1.

U.S. Manufacturer Gross Prescription Drug Prices as a Percentage of Prices in Selected Other Countries, All Drugs, 2022

SOURCE: Authors’ analysis of 2022 sales and volume data from IQVIA, “MIDAS,” webpage, undated (run date May 19, 2023).

NOTE: All countries refers to all 33 OECD comparison countries combined. Other countries’ prices are set to 100. Biologics were excluded from unbranded generics. Only some presentations sold in each country contribute to bilateral comparisons. Brand-name originators and Unbranded generics reflect IQVIA's assignment of drug products in individual countries.